Shoreline Biosciences, Inc.

Clinically effective immunotherapies using intelligently engineered iPSC-derived allogeneic cells

Add To Watchlist
General Information
Company Name
Shoreline Biosciences, Inc.
Founded Year
2020
Location (Offices)
La Jolla, United States +1
Founders / Decision Makers
William Sandborn - Co-Founder and Chief Medical Officer Kleanthis G. Xanthopoulos - Co-Founder Vanessa Jacoby - Chief Financial Officer Dan S. Kaufman - Co-Founder and Acting Chief Scientific Officer Scott Forrest - Chief Business Officer Robert Hollingsworth - Chief Scientific Officer Mohammad A. El-Kalay - Senior VP and Head of CMC
Number of Employees
74
Industries
Biotechnology, Health Care, Life Sciences
Funding Stage
Series B
Social Media

Shoreline Biosciences, Inc. - Company Profile

Shoreline Biosciences is a biotechnology startup founded in 2020 with a focus on developing clinically effective immunotherapies using intelligently engineered iPSC-derived allogeneic cells. The company's proprietary cell therapy technology platform is centered around deep expertise in iPSC differentiation methods and genetic programming of the IL-15/CISH pathway to enhance metabolic fitness and persistence of the engineered NK Cells, ultimately improving anti-cancer activity.

The company, headquartered in the United States, recently received a significant $140.00M Series B investment on 02 November 2021. The investment came from a consortium of prominent investors including BVF Partners, Commodore Capital, Cormorant Asset Management, Janus Handerson, Kite Pharma, Kingdon Capital Management, Superstring Capital, Stork Capital, Eventide, and Wedbush Securities.

Shoreline Biosciences operates at the intersection of biotechnology and health care, positioning itself as a key player in the rapidly evolving landscape of immunotherapy. With its innovative approach and substantial support from reputable investors, the company is poised to make significant strides in the field of cancer treatment and beyond.

Taxonomy: immunotherapy, cell therapy, IPSC-derived cells, allogeneic cells, genetic programming, IL-15/CISH pathway, NK cells, cancer treatment, metabolic fitness, proprietary technology, stem cell research, oncology, clinical efficacy, cell engineering

Funding Rounds & Investors of Shoreline Biosciences, Inc. (3)

View All
Funding Stage Amount No. Investors Investors Date
Series B $140.00M 10
Commodore Capital, investor in Shoreline Biosciences, Inc.'s Series B round Janus Handerson, investor in Shoreline Biosciences, Inc.'s Series B round Kite Pharma, investor in Shoreline Biosciences, Inc.'s Series B round Cormorant Asset Management, investor in Shoreline Biosciences, Inc.'s Series B round Kingdon Capital Management, investor in Shoreline Biosciences, Inc.'s Series B round Superstring Capital, investor in Shoreline Biosciences, Inc.'s Series B round Eventide Asset Management, investor in Shoreline Biosciences, Inc.'s Series B round Stork Capital, investor in Shoreline Biosciences, Inc.'s Series B round
Wedbush Securities, Biotechnology Value Fund 		02 Nov 2021
Series A $43.00M - 07 Feb 2021
Seed Round $3.00M - 17 Jul 2020

Latest News of Shoreline Biosciences, Inc.

View All

No recent news or press coverage available for Shoreline Biosciences, Inc..

Similar Companies to Shoreline Biosciences, Inc.

View All
ScienCell Research Laboratories - Similar company to Shoreline Biosciences, Inc.
ScienCell Research Laboratories Helping the Scientists of Today Discover the Science of Tomorrow
PELOBiotech GmbH - Similar company to Shoreline Biosciences, Inc.
PELOBiotech GmbH The one-stop shop for human and animal primary cells, customized media, and cell culture tools.
BetaLife - Similar company to Shoreline Biosciences, Inc.
BetaLife A stem cell therapy company that is developing regenerative medicine for diabetes.
Celltex Therapeutics Corporation - Similar company to Shoreline Biosciences, Inc.
Celltex Therapeutics Corporation A Houston-based biotech company focused on breakthroughs using autologous, adipose-derived Mesenchymal Stem Cells (MSCs)
Cellular Engineering Technologies - Similar company to Shoreline Biosciences, Inc.
Cellular Engineering Technologies Innovative biopharmaceutical advancements shaping patient therapy for a healthier future.
Circle Decoration Circle Decoration

Want to dive deeper into Shoreline Biosciences, Inc.? Join now to access exclusive insights and find similar companies like this — powered by AI analytics.

Register Now